• Published 2019

New treatment options for patients with metabolic syndrome

@inproceedings{WoakowskaKapon2019NewTO,
  title={New treatment options for patients with metabolic syndrome},
  author={Beata Wożakowska-Kapłon},
  year={2019}
}
The occurrence of metabolic syndrome is a risk factor for developing cardiovascular disease. Moreover, the size of low-density lipoprotein (LDL) particles, and liver dysfunction identified as non-alcoholic fatty liver disease (NAFLD), both represent important biomarkers for the development of cardiometabolic risk in patients with metabolic syndrome. Patients being treated with bergamot polyphenolic fraction show significant reductions in fasting plasma glucose, serum LDL cholesterol, and… CONTINUE READING

Figures and Tables from this paper.

References

Publications referenced by this paper.
SHOWING 1-10 OF 16 REFERENCES

Studies on the protective role of Bergamot polyphenols in doxorubicin - induced cardiotoxicity

BF Holmes, EJ Kurth-Kraczek, WW Winder
  • 2016

The protective role of bergamot polyphenolic fraction on several animal models of pain

SP Nisticò, U Bottoni, M Gliozzi
  • 2016

roku

M Paszkiewicz, A Budzyńska, B Różalska
  • Kardiol Pol
  • 2016